ClinicalTrials.Veeva

Menu

The Effects of Visior on Ocular Hemodynamics

V

Visior Technologies

Status

Completed

Conditions

Primary Open Angle Glaucoma

Treatments

Device: VISIOR video goggles

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT02959593
1602760177

Details and patient eligibility

About

To determine the relationship between the affects of viewing commercially available content through the VISIOR video goggles and ocular blood flow in glaucoma patients and healthy subjects.

Full description

To determine if glaucoma patients and healthy subject experience any alteration in localized retinal blood flow after retinal stimulation by viewing commercially available content through the VISIOR video goggles.

Both groups will undergo measurements of arterial blood pressure, cardiac pulse (heart rate), intraocular pressure, and retinal blood flow using Heidelberg retinal flowmetry (Heidelberg Engineering, Heidelberg, Germany) at baseline and then ten minutes, thirty minutes, and sixty minutes after viewing commercially available content through the VISIOR video goggles for thirty minutes.

Enrollment

35 patients

Sex

All

Ages

30+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients with open-angle glaucoma 30 years or older, free from other ophthalmic disease, free from diabetes, beta agonists and uncontrolled blood pressure.

Exclusion criteria

  • Women who are pregnant or lactating or who plan to become pregnant (self reporting); smoker during last ten years (self reporting); systemic diseases that may interfere with blood flow measurements or wearing the goggles.
  • In addition, 10 healthy subjects, age 18 or older, free from eye disease will be enrolled. Identical exclusion criteria apply to this healthy group. Identical procedures apply to this group, which only differs by ocular health status.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Single Blind

35 participants in 2 patient groups

Glaucoma patients
Experimental group
Description:
To view commercially available content through the VISIOR video goggles for thirty minutes
Treatment:
Device: VISIOR video goggles
Healthy subjects
Experimental group
Description:
To view commercially available content through the VISIOR video goggles for thirty minutes.
Treatment:
Device: VISIOR video goggles

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems